![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » RANBAXY GETS FDA OKAY FOR ANTI-DIARRHOEAL DRUG
RANBAXY GETS FDA OKAY FOR ANTI-DIARRHOEAL DRUG
Ranbaxy Laboratories Ltd has announced that the company has received approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Loperamide Hydrochloride and Simethicone Tablets, 2 mg / 125 mg (OTC). The Hindu Business Line (http://www.thehindubusinessline.com/businessline/blnus/02111507.htm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct